Mostafa Ibrahim, MD form the Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology at Erasme Hospital, Université Libre de Bruxelles, in Brussels, Belgium presents this video case “Active bleeding caused by portal hypertensive gastropathy.”
Portal hypertensive gastropathy is a serious adverse event of portal hypertension. It is difficult to treat due to the diffuse nature of bleeding. Hemospray that is the novel hemostatic powder licensed for non-variceal bleeding and it has shown effectiveness in achieving hemostasis in bleeding peptic ulcers and bleeding secondary to gastric malignancies. Hemospray is a non contact technique which allow diffuse application of the hemostatic powder. We were able to achieve hemostasis after covering the bleeding region with the hemostatic powder. We think that Hemospray may be used as a rescue therapy specially in diffuse bleeding originating from portal hypertensive gastropathy.
I think that the usage of hemostatic powder will have a great future in the manamegmnt of such difficult situation. I feel that using such technique will induce a new paradigm shift in changing patients conditions from the Acute bleeder patient to a chronic patient with a particular disease. This change in patient condition will give the endoscopists the optimal conations to treat this group of patients.
The most important tip which I would like to transfer is that you should do a control endoscopy in such cases because the powder will treat bleeding but it wont treat the primary disease.
Watch the video case here:
The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.